FREE Account Opening + No Clearing Fees
Loading...

JFL Life Sciences IPO vs Rhetan TMT IPO

Comparision between JFL Life Sciences IPO and Rhetan TMT IPO.

IPO Details

JFL Life Sciences IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Rhetan TMT IPO is a SME Fixed Price Issue proposed to list at BSE SME.

  JFL Life Sciences IPO Rhetan TMT IPO
Logo JFL Life Sciences IPO Logo Rhetan TMT IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At NSE SME BSE SME
Lead Managers GYR Capital Advisors Private Limited Aryaman Financial Services Limited
Registrar Kfin Technologies Limited Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of JFL Life Sciences IPO is up to ₹18.17 Cr whereas the issue size of the Rhetan TMT IPO is up to ₹56.00 Cr. The final issue price of JFL Life Sciences IPO is ₹61.00 per share and of Rhetan TMT IPO is ₹70.00 per share.

  JFL Life Sciences IPO Rhetan TMT IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹61.00 per share ₹70.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 2000 shares 2000 shares
Fresh Issue Size 29,78,000 shares 80,00,000 shares
Fresh Issue Size (Amount) up to ₹18.17 Cr up to ₹56.00 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 29,78,000 shares 80,00,000 shares
Issue Size Total (Amount) up to ₹18.17 Cr up to ₹56.00 Cr

IPO Timetable

JFL Life Sciences IPO opens on Aug 25, 2022, while Rhetan TMT IPO opens on Aug 22, 2022. The closing date of JFL Life Sciences IPO and Rhetan TMT IPO is Aug 30, 2022, and Aug 25, 2022, respectively.

  JFL Life Sciences IPO Rhetan TMT IPO
Anchor Bid Date
Issue Open Aug 25, 2022 Aug 22, 2022
Issue Close Aug 30, 2022 Aug 25, 2022
Basis Of Allotment (Tentative) Sep 05, 2022 Aug 30, 2022
Initiation of Refunds (Tentative) Sep 06, 2022 Sep 01, 2022
Credit of Share (Tentative) Sep 07, 2022 Sep 02, 2022
Listing date (Tentative) Sep 08, 2022 Sep 05, 2022
Anchor Lockin End date 1 Oct 05, 2022 Sep 29, 2022
Anchor Lockin End date 2 Dec 04, 2022 Nov 28, 2022

Financials

JFL Life Sciences IPO P/E ratio is 26.52, as compared to Rhetan TMT IPO P/E ratio of 63.64.

  JFL Life Sciences IPO Rhetan TMT IPO
Financial
JFL Life Sciences Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and Surplus
31-Aug-191614.963177.9630.25501.49459.2
31-Mar-202432.593020.4136.04537.53495.24
31-Mar-212900.693286.8954.21687.25637.55
28-Feb-223662.862563.06253.281096.52294.48
Amount in ₹ Lakhs
Rhetan TMT Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and Surplus
31-Mar-203046.862008.26-58.0430.21-311.65
31-Mar-213980.655213.0113.44783.65-298.21
31-Mar-225900.066703.45234.572313.211046.35
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 92.52% 99.62%
Promoter Shareholding (Post-Issue) 67.47% 62.12%
P/E Ratio 26.52 63.64
Market Cap ₹67.09 Cr. ₹148.75 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the JFL Life Sciences IPO retail investors (RII) are offered 14,14,000 shares while in Rhetan TMT IPO retail investors are offered 14,14,000 shares. Qualified institutional buyers (QIB) are offered in JFL Life Sciences IPO and in Rhetan TMT IPO.

  JFL Life Sciences IPO Rhetan TMT IPO
Anchor Investor Reserveration
Market Maker Reserveration 1,50,000 shares 4,16,000 shares
QIB
NII 14,14,000 shares 37,92,000 shares
RII 14,14,000 shares 37,92,000 shares
Employee
Others
Total 28,28,000 shares 75,84,000 shares

Bids Received (Subscription)

JFL Life Sciences IPO subscribed 8.93x in total, whereas Rhetan TMT IPO subscribed 1.47x.

  JFL Life Sciences IPO Rhetan TMT IPO
QIB (times)
NII (times) 6.19x 2.18x
Big NII (times)
Small NII (times)
RII (times) 11.66x 0.76x
Employee (times)
Other (times)
Total (times) 8.93x 1.47x

Comments

Add a public comment...